Dog Gets Special Stem Cell Treatment To Relieve Pain « CBS Denver – CBS Local
CBS Local |
Dog Gets Special Stem Cell Treatment To Relieve Pain « CBS Denver
CBS Local A dog received stem cell treatment at the Aspen Arbor Animal Hospital in Broomfield on Wednesday. |
CBS Local |
Dog Gets Special Stem Cell Treatment To Relieve Pain
CBS Local MediVet’s stem cell therapy surpasses any other treatment options for elbow or hip dysplasia and arthritis in dogs and cats. Stem cells rebuild the cartilage in joints and reduce painful inflammation naturally. They are healing cells, naturally found … |
Newsroom |
‘We’ve reached peak antibiotics’
Newsroom “Taking advantage of the fact that bacteria are so good at swapping bits of DNA, we and others have shown that you can employ ‘synthetic biology‘ approaches to transfer these blueprints to a new host – a bacterium that we can grow in the lab – and a … |
|
Discussing The Future Of CRISPR-Cas: Gene Editing Takes Center Stage At CRISPRcon
SYS-CON Media (press release) “Fulfilling the promise and the potential of CRISPR technology requires collaboration and thoughtful, open dialogue,” says Jennifer Doudna, professor at the University of California, Berkeley, and a pioneer in the field of CRISPR biology and genome … |
Chicago Tribune |
About CAR–T leukemia therapy, part of a new wave in cancer treatment
ABC News The committee’s approval for CAR–T therapy applies to children and young adults, ages 3 to 25, with a form of leukemia called relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). ALL is the most common type of cancer in children, with … First gene therapy — ‘a true living drug’ — on the cusp of FDA approvalChicago Tribune Novartis CAR–T Therapy Drug Recommended by FDA PanelNasdaq FDA may approve goundbreaking cancer treatment that uses body’s immune system to fight diseaseThe Independent Fortune –Gizmodo –FDA –New York Times all 245 news articles » |
Popular Science |
Why CAR T-cell immunotherapy is such a big deal for cancer treatment
Popular Science The treatment is known in the medical community as CAR T-cell therapy. It involves removing some T-cells—a type of white blood cell—from a patient’s blood. Then researchers tweak the outside of each cell in the lab by adding a receptor called CAR … CAR–T gene therapy for leukemia clears FDA hurdleCBS News A New Dawn: First CAR T Cell Recommended for FDA ApprovalMedscape FDA Panel Unanimously Recommends Approval for Novartis’ CAR T-Cell Therapy CTL019Genetic Engineering & Biotechnology News Washington Post –FierceBiotech –ABC News –FDA all 163 news articles » |